Skip to main content
. 2012 Jul 30;21(21):4793–4804. doi: 10.1093/hmg/dds302

Figure 7.

Figure 7.

TPMT activity in NALM6 cells heterologously expressing TPMT*1 or TPMT*3A and with knock-down of PACSIN2. After knock-down of PACSIN2, a significant (30%) decrease in TPMT activity was observed in cells heterologously expressing TPMT*1 (P-value Welch t-test = 0.0036).